FindTrial
Sign In

Single arm:None

9 trials

Sponsors

Masaaki Ito, The Second Affiliated Hospital of Anhui Medical University, Chinese PLA General Hospital, The First Affiliated Hospital of USTC, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University

Conditions

Adenocarcinoma of the stomach or gastroesophageal junctionColorectal cancerCoronary heart diseaseLiver cancerLymphomasglioblastomalarge B cell lymphomalumbar radicular pain

Early Phase 1

Automated Laparoscopic Colorectal Surgery Workflow Recognition using Artificial Intelligence: Experimental Research
Active, not recruitingChiCTR2000030488
Masaaki ItoColorectal cancer
Start: 2009-04-01Updated: 2020-03-09
Dynamic changes of inflammatory factors and platelet aggregation rate before and after percutaneous coronary intervention in patients with unstable angina pectoris and their effect on prognosis
RecruitingChiCTR2100044938
The Second Affiliated Hospital of Anhui Medical UniversityCoronary heart disease
Start: 2021-03-22Updated: 2021-11-02
Color Doppler Ultrasonography predicts Successful Caudal epidural Block
Active, not recruitingChiCTR2600128963
Shanghai Sixth People’s Hospitallumbar radicular pain
Start: 2026-08-01Updated: 2026-08-03

Phase 4

Dose management study of apatinib mesylate combined with second-line chemotherapy in the treatment of gastric or gastroesophageal junction adenocarcinoma
RecruitingChiCTR2100045737
The First Affiliated Hospital of USTCAdenocarcinoma of the stomach or gastroesophageal junction
Start: 2021-05-01Updated: 2021-12-06

Unknown Phase

The application of nituzumab after the operation of EGFR-positive glioblastoma Real world research
RecruitingChiCTR2100045194
Chinese PLA General Hospitalglioblastoma
Start: 2021-04-01Updated: 2021-11-08
REAL-TIME VASCULAR ANATOMICAL IMAGE NAVIGATION FOR LAPAROSCOPIC SURGERY: A RETROSPECTIVE FEASIBILITY STUDY
Active, not recruitingChiCTR2100047625
Masaaki ItoColorectal cancer
Start: 2009-04-01Updated: 2022-02-21
A non-interference clinical study to evaluate the treatment of adult large B-cell lymphoma (r/r LBCL) with Axicabtagene Ciloleucel Injection that is refractory to first-line chemoimmunotherapy or relapses within 12 months of first-line chemoimmunotherapy.
Active, not recruitingChiCTR2400086700
Ruijin Hospital, School of Medicine, Shanghai Jiaotong Universitylarge B cell lymphoma
Start: 2024-07-15Updated: 2024-07-15
Efficacy and Safety of Ripertamab With or Without Other Drugs in B-cell Non-Hodgkin's Lymphomas
RecruitingChiCTR2400087275
Institute of Hematology and Oncology, Harbin The First HospitalLymphomas
Start: 2023-08-19Updated: 2024-07-29
Implementation of biomimetic 3D bioprinting technology in selecting optimal regimens as adjuvant therapy to prevent hepatocellular carcinoma recurrence after liver resection or ablation: a feasibility study
RecruitingChiCTR2500114608
Department of Surgery, The University of Hong KongLiver cancer
Start: 2025-12-15Updated: 2026-01-05

Related Papers

Effects of Body Mass Index and Body Weight on Plasma Concentration of Ticagrelor and Platelet Aggregation Rate in Patients with Unstable Angina in a Chinese Han Population
Reviews in Cardiovascular Medicine2024-03-04